VivoSim Labs, INC.
VIVS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001497253
In the last 90 days, VivoSim Labs, INC. insiders filed 1 open-market purchase and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $109.7K in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in VivoSim Labs, INC. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +3 vs. Q1 2025
- Shares held
- 128.6K
- +64.9K (+101.9%) vs. Q1 2025
- Total value
- $189.0K
- +$46.4K (+32.5%) vs. Q1 2025
- New holders
- 8
- 5 more added
- Sold out
- 5
- 3 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $109.7K |
| Q1 2026 | 24 | $140.0K |
| Q4 2025 | 27 | $189.3K |
| Q3 2025 | 29 | $644.4K |
| Q2 2025 | 26 | $189.0K |
| Q1 2025 | 23 | $142.6K |
| Q4 2024 | 32 | $1.15M |
| Q3 2024 | 31 | $1.24M |
| Q2 2024 | 34 | $1.77M |
| Q1 2024 | 34 | $911.7K |
| Q4 2023 | 36 | $932.1K |
| Q3 2023 | 34 | $894.3K |
| Q2 2023 | 36 | $1.35M |
| Q1 2023 | 39 | $1.76M |
| Q4 2022 | 42 | $2.64M |
| Q3 2022 | 43 | $4.07M |
| Q2 2022 | 44 | $3.43M |
| Q1 2022 | 39 | $7.42M |
| Q4 2021 | 48 | $8.23M |
| Q3 2021 | 43 | $14.9M |
| Q2 2021 | 51 | $21.4M |
| Q1 2021 | 46 | $23.1M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding VivoSim Labs, INC.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 57,493 | $84.5K | 0.00% | +57,493 | New |
| Vanguard Group Inc | 22,374 | $32.9K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 16,727 | $24.6K | 0.00% | +16,727 | New |
| UBS Group AG | 14,104 | $20.7K | 0.00% | +14,051+26,511.3% | Added |
| BlackRock, Inc. | 11,818 | $17.4K | 0.00% | −26−0.2% | Reduced |
| Raymond James Financial Inc | 3,313 | $4.87K | 0.00% | +3,313 | New |
| Tower Research Capital LLC (TRC) | 1,706 | $2.51K | 0.00% | +1,527+853.1% | Added |
| SBI Securities Co., Ltd. | 219 | $322 | 0.00% | +50+29.6% | Added |
| Allworth Financial LP | 208 | $306 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 160 | $235 | 0.00% | 00.0% | Unchanged |
| Albion Financial Group | 159 | $234 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 117 | $168 | 0.00% | −16−12.0% | Reduced |
| Morgan Stanley | 72 | $106 | 0.00% | −4,918−98.6% | Reduced |
| Farther Finance Advisors, LLC | 58 | $85 | 0.00% | +58 | New |
| Bank of America Corp | 33 | $48 | 0.00% | +10+43.5% | Added |
| FMR LLC | 10 | $15 | 0.00% | +10 | New |
| JPMorgan Chase & Co | 3 | $4 | 0.00% | 00.0% | Unchanged |
| McIlrath & Eck, LLC | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Golden State Wealth Management, LLC | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Total Investment Management Inc | 2 | $3 | 0.00% | +2 | New |
| Koesten, Hirschmann & Crabtree, INC. | 2 | $3 | 0.00% | +2 | New |
| Harbour Investments, Inc. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $1 | 0.00% | +1 | New |
| Royal Bank of Canada | 8 | $0 | 0.00% | +2+33.3% | Added |
| TSFG, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Prescott Group Capital Management, L.L.C. | 0 | $0 | 0.00% | −23,375−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Cullen/Frost Bankers, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |